{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:22:41Z","timestamp":1783038161153,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2021R1A2C2009095"],"award-info":[{"award-number":["NRF-2021R1A2C2009095"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51716-3","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:35:46Z","timestamp":1777862146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 spike protein exerts an anti-cancer effect in A549 cells in association with MEG3 and BCYRN1 regulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Jung-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengmin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeseon","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunseo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"2","key":"51716_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell 181 (2), 271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (2020). e8.","journal-title":"cell"},{"key":"51716_CR2","doi-asserted-by":"publisher","first-page":"701501","DOI":"10.3389\/fimmu.2021.701501","volume":"12","author":"D Mart\u00ednez-Flores","year":"2021","unstructured":"Mart\u00ednez-Flores, D. et al. SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants. Front. Immunol. 12, 701501. https:\/\/doi.org\/10.3389\/fimmu.2021.701501 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"51716_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23 (1), 3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"51716_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","volume":"6","author":"FX Heinz","year":"2021","unstructured":"Heinz, F. X. & Stiasny, K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. npj Vaccines. 6 (1), 104. https:\/\/doi.org\/10.1038\/s41541-021-00369-6 (2021).","journal-title":"npj Vaccines"},{"issue":"3","key":"51716_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang, W. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21 (3), 335\u2013337. https:\/\/doi.org\/10.1016\/S1470-2045(20)30096-6 (2020).","journal-title":"Lancet Oncol."},{"issue":"3","key":"51716_CR6","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.beha.2022.101401","volume":"35","author":"E Davitt","year":"2022","unstructured":"Davitt, E. et al. COVID-19 disease and immune dysregulation. Best Pract. Res. Clin. Haematol. 35 (3), 101401. https:\/\/doi.org\/10.1016\/j.beha.2022.101401 (2022).","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"1","key":"51716_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"I-E Galani","year":"2021","unstructured":"Galani, I-E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22 (1), 32\u201340. https:\/\/doi.org\/10.1038\/s41590-020-00840-x (2021).","journal-title":"Nat. Immunol."},{"issue":"10","key":"51716_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26 (10), 1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9 (2020).","journal-title":"Nat. Med."},{"key":"51716_CR9","doi-asserted-by":"publisher","first-page":"104428","DOI":"10.1016\/j.meegid.2020.104428","volume":"85","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Han, X. & Shi, Y. Comparative analysis of SARS-CoV-2 receptor ACE2 expression in multiple solid tumors and matched non-diseased tissues. Infect. Genet. Evol. 85, 104428. https:\/\/doi.org\/10.1016\/j.meegid.2020.104428 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"51716_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2021.05.014","volume":"157","author":"M Provencio","year":"2021","unstructured":"Provencio, M. et al. Lung cancer patients with COVID-19 in Spain: GRAVID study. Lung cancer. 157, 109\u2013115. https:\/\/doi.org\/10.1016\/j.lungcan.2021.05.014 (2021).","journal-title":"Lung cancer"},{"issue":"8","key":"51716_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.6084\/m9.figshare.12666698","volume":"1","author":"M Rugge","year":"2020","unstructured":"Rugge, M., Zorzi, M. & Guzzinati, S. SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer. Nat. cancer. 1 (8), 784\u2013788. https:\/\/doi.org\/10.6084\/m9.figshare.12666698 (2020).","journal-title":"Nat. cancer"},{"issue":"10","key":"51716_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","volume":"31","author":"J Luo","year":"2020","unstructured":"Luo, J. et al. COVID-19 in patients with lung cancer. Ann. Oncol. 31 (10), 1386\u20131396 (2020).","journal-title":"Ann. Oncol."},{"issue":"1","key":"51716_CR13","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1016\/j.annonc.2020.06.007","volume":"11","author":"J Fajnzylber","year":"2020","unstructured":"Fajnzylber, J. et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11 (1), 5493. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.007 (2020).","journal-title":"Nat. Commun."},{"issue":"10","key":"51716_CR14","doi-asserted-by":"publisher","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","volume":"14","author":"YH Chung","year":"2020","unstructured":"Chung, Y. H., Beiss, V., Fiering, S. N. & Steinmetz, N. F. COVID-19 vaccine frontrunners and their nanotechnology design. ACS nano. 14 (10), 12522\u201312537. https:\/\/doi.org\/10.1021\/acsnano.0c07197 (2020).","journal-title":"ACS nano"},{"issue":"1","key":"51716_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/wo.2021.103829","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S. & Barsouk, A. Epidemiology of lung cancer. Contemp. Oncology\/Wsp\u00f3\u0142czesna Onkologia. 25 (1), 45\u201352. https:\/\/doi.org\/10.5114\/wo.2021.103829 (2021).","journal-title":"Contemp. Oncology\/Wsp\u00f3\u0142czesna Onkologia"},{"issue":"3","key":"51716_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71 (3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"51716_CR17","doi-asserted-by":"publisher","unstructured":"Ji, X. et al. (eds) Epidemiological Analysis of Global and Regional Lung Cancer Mortality: Based on 30-Year Data Analysis of Global Burden Disease Database (MDPI, 2023). https:\/\/doi.org\/10.3390\/healthcare11222920","DOI":"10.3390\/healthcare11222920"},{"issue":"6","key":"51716_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 68 (6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"Cancer J. Clin."},{"key":"51716_CR19","doi-asserted-by":"publisher","unstructured":"SiegelRL, GiaquintoAN & Jemal, A. Cancer statistics, 2024. Cancer J. Clin. 74 (1). https:\/\/doi.org\/10.3322\/caac.21820 (2024).","DOI":"10.3322\/caac.21820"},{"issue":"10","key":"51716_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/cac2.12359","volume":"42","author":"P Chen","year":"2022","unstructured":"Chen, P., Liu, Y., Wen, Y. & Zhou, C. Non-small cell lung cancer in China. Cancer Commun. 42 (10), 937\u2013970. https:\/\/doi.org\/10.1002\/cac2.12359 (2022).","journal-title":"Cancer Commun."},{"key":"51716_CR21","doi-asserted-by":"publisher","unstructured":"SiegelRL, MillerKD, FuchsHE & JemalA Cancer statistics, 2022. Cancer J. Clin. 72 (1). https:\/\/doi.org\/10.3322\/caac.21708 (2022).","DOI":"10.3322\/caac.21708"},{"issue":"1","key":"51716_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"SiegelRL, MillerKD & JemalA Cancer statistics, 2018. Cancer J. Clin. 68 (1), 7\u201330. https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"Cancer J. Clin."},{"key":"51716_CR23","doi-asserted-by":"publisher","unstructured":"Hombach, S. & Kretz, M. Non-coding RNAs: classification, biology and functioning. Non-coding RNAs colorectal cancer. 3\u201317. https:\/\/doi.org\/10.1007\/978-3-319-42059-2_1 (2016).","DOI":"10.1007\/978-3-319-42059-2_1"},{"issue":"9","key":"51716_CR24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3390\/ijms20092279","volume":"20","author":"G Botti","year":"2019","unstructured":"Botti, G., Scognamiglio, G., Aquino, G., Liguori, G. & Cantile, M. LncRNA HOTAIR in tumor microenvironment: what role? Int. J. Mol. Sci. 20 (9), 2279. https:\/\/doi.org\/10.3390\/ijms20092279 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"51716_CR25","doi-asserted-by":"publisher","first-page":"1467151","DOI":"10.3389\/fimmu.2024.1467151","volume":"15","author":"J Jiao","year":"2024","unstructured":"Jiao, J., Zhao, Y., Li, Q., Jin, S. & Liu, Z. LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling. Front. Immunol. 15, 1467151. https:\/\/doi.org\/10.3389\/fimmu.2024.1467151 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"51716_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-021-00678-8","volume":"7","author":"S Zhao","year":"2021","unstructured":"Zhao, S., Zhang, X., Chen, S. & Zhang, S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell. Death Discovery. 7 (1), 283. https:\/\/doi.org\/10.1038\/s41420-021-00678-8 (2021).","journal-title":"Cell. Death Discovery"},{"key":"51716_CR27","doi-asserted-by":"publisher","unstructured":"Challenor, S. & Tucker, D. SARS-CoV\u20102\u2010induced remission of Hodgkin lymphoma. Br. J. Haematol. 192 (3). https:\/\/doi.org\/10.1111\/bjh.17116 (2021).","DOI":"10.1111\/bjh.17116"},{"issue":"1","key":"51716_CR28","doi-asserted-by":"publisher","first-page":"2603607","DOI":"10.1155\/2022\/2603607","volume":"2022","author":"M Barkhordar","year":"2022","unstructured":"Barkhordar, M. et al. Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease\u201019. Case Rep. Hematol. 2022 (1), 2603607. https:\/\/doi.org\/10.1155\/2022\/2603607 (2022).","journal-title":"Case Rep. Hematol."},{"issue":"2","key":"51716_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.htct.2022.01.017","volume":"44","author":"RL Baptista","year":"2022","unstructured":"Baptista, R. L., Moreira, R. & Rego, E. COVID-19 induced follicular lymphoma remission. Hematol. Transfus. Cell. Therapy. 44 (2), 291\u2013292. https:\/\/doi.org\/10.1016\/j.htct.2022.01.017 (2022).","journal-title":"Hematol. Transfus. Cell. Therapy"},{"issue":"8","key":"51716_CR30","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1007\/s00259-021-05275-6","volume":"48","author":"M Sollini","year":"2021","unstructured":"Sollini, M., Gelardi, F., Carlo-Stella, C. & Chiti, A. Complete remission of follicular lymphoma after SARS-CoV-2 infection: From the flare phenomenon to the abscopal effect. Eur. J. Nucl. Med. Mol. Imaging. 48 (8), 2652\u20132654. https:\/\/doi.org\/10.1007\/s00259-021-05275-6 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"51716_CR31","doi-asserted-by":"publisher","first-page":"e2020047","DOI":"10.23750\/abm.v91i3.10141","volume":"91","author":"F Pasin","year":"2020","unstructured":"Pasin, F. et al. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma. Acta Bio Medica: Atenei Parmensis. 91 (3), e2020047. https:\/\/doi.org\/10.23750\/abm.v91i3.10141 (2020).","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"key":"51716_CR32","doi-asserted-by":"publisher","unstructured":"Antwi-Amoabeng, D., Ulanja, M. B., Beutler, B. D. & Reddy, S. V. Multiple myeloma remission following COVID-19: an observation in search of a mechanism (a case report). Pan Afr. Med. J. 39 (1). https:\/\/doi.org\/10.11604\/pamj.2021.39.117.30000 (2021).","DOI":"10.11604\/pamj.2021.39.117.30000"},{"key":"51716_CR33","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.lrr.2022.100336","volume":"18","author":"H B\u00fclb\u00fcl","year":"2022","unstructured":"B\u00fclb\u00fcl, H., Nazl\u0131, H. E., Olgun, A., Togay, A. & Kahraman, D. S. Spontaneous remission of chronic lymphocytic leucemia in a patient with SARS-CoV2. Leuk. Res. Rep. 18, 100336. https:\/\/doi.org\/10.1016\/j.lrr.2022.100336 (2022).","journal-title":"Leuk. Res. Rep."},{"issue":"5","key":"51716_CR34","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/curroncol28050294","volume":"28","author":"T Buchler","year":"2021","unstructured":"Buchler, T., Fiser, L., Benesova, J., Jirickova, H. & Votrubova, J. Spontaneous regression of metastatic renal cell carcinoma after SARS-CoV-2 infection: a report of two cases. Curr. Oncol. 28 (5), 3403\u20133407. https:\/\/doi.org\/10.3390\/curroncol28050294 (2021).","journal-title":"Curr. Oncol."},{"key":"51716_CR35","doi-asserted-by":"publisher","first-page":"175883592110114","DOI":"10.1177\/17588359211011455","volume":"13","author":"A Ottaiano","year":"2021","unstructured":"Ottaiano, A. et al. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Therapeutic Adv. Med. Oncol. 13, 17588359211011455. https:\/\/doi.org\/10.1177\/17588359211011455 (2021).","journal-title":"Therapeutic Adv. Med. Oncol."},{"key":"51716_CR36","doi-asserted-by":"publisher","first-page":"175883592211383","DOI":"10.1177\/17588359221138388","volume":"14","author":"A Ottaiano","year":"2022","unstructured":"Ottaiano, A. et al. Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-CoV-2 infection. Therapeutic Adv. Med. Oncol. 14, 17588359221138388. https:\/\/doi.org\/10.1177\/17588359221138388 (2022).","journal-title":"Therapeutic Adv. Med. Oncol."},{"issue":"6","key":"51716_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/bjd.20630","volume":"185","author":"T Gambichler","year":"2021","unstructured":"Gambichler, T. et al. Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS\u2010CoV\u20102 vaccination. Br. J. Dermatol. 185 (6), 1259\u20131262. https:\/\/doi.org\/10.1111\/bjd.20630 (2021).","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"51716_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-023-04110-w","volume":"21","author":"C Meo","year":"2023","unstructured":"Meo, C. et al. Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment. J. Translational Med. 21 (1), 273. https:\/\/doi.org\/10.1186\/s12967-023-04110-w (2023).","journal-title":"J. Translational Med."},{"issue":"4","key":"51716_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/ol.2024.14302","volume":"27","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Tumor reduction after SARS\u2013CoV\u20132 infection in a patient with lung cancer: A case report. Oncol. Lett. 27 (4), 169. https:\/\/doi.org\/10.3892\/ol.2024.14302 (2024).","journal-title":"Oncol. Lett."},{"issue":"4","key":"51716_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2022.5332","volume":"60","author":"Y-S Li","year":"2022","unstructured":"Li, Y-S., Ren, H-C. & Cao, J-H. Correlation of SARS\u2013CoV\u20132 to cancer: Carcinogenic or anticancer? Int. J. Oncol. 60 (4), 1\u201317. https:\/\/doi.org\/10.3892\/ijo.2022.5332 (2022).","journal-title":"Int. J. Oncol."},{"issue":"18","key":"51716_CR41","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3390\/cells11182787","volume":"11","author":"H Han","year":"2022","unstructured":"Han, H., Lee, S-O., Xu, Y., Kim, J-E. & Lee, H-J. SPHK\/HIF-1\u03b1 signaling pathway has a critical role in chrysin-induced anticancer activity in hypoxia-induced PC-3 cells. Cells 11 (18), 2787. https:\/\/doi.org\/10.3390\/cells11182787 (2022).","journal-title":"Cells"},{"issue":"1","key":"51716_CR42","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1038\/s41598-024-65447-w","volume":"14","author":"H Han","year":"2024","unstructured":"Han, H., Kim, J-E. & Lee, H-J. Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model. Sci. Rep. 14 (1), 14545. https:\/\/doi.org\/10.1038\/s41598-024-65447-w (2024).","journal-title":"Sci. Rep."},{"issue":"6","key":"51716_CR43","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/biomedicines10061370","volume":"10","author":"Y-K Lee","year":"2022","unstructured":"Lee, Y-K. et al. a Key Transmitter of HIF-1\u03b1 and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells. Biomedicines 10 (6), 1370. https:\/\/doi.org\/10.3390\/biomedicines10061370 (2022).","journal-title":"Biomedicines"},{"issue":"3","key":"51716_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8","volume":"183","author":"W Chen","year":"1997","unstructured":"Chen, W., B\u00f6cker, W., Brosius, J. & Tiedge, H. Expression of neural BC200 RNA in human tumours. J. Pathology: J. Pathological Soc. Great Br. Irel. 183 (3), 345\u2013351. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199711)183:3%3C345::AID-PATH930%3E3.0.CO;2-8 (1997).","journal-title":"J. Pathology: J. Pathological Soc. Great Br. Irel."},{"issue":"22","key":"51716_CR45","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.3390\/cancers14225648","volume":"14","author":"M Sheinin","year":"2022","unstructured":"Sheinin, M., Jeong, B., Paidi, R. K. & Pahan, K. Regression of lung cancer in mice by intranasal administration of SARS-CoV-2 Spike S1. Cancers 14 (22), 5648 (2022).","journal-title":"Cancers"},{"issue":"3","key":"51716_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/cancers14225648","volume":"39","author":"BD Johnson","year":"2022","unstructured":"Johnson, B. D. et al. SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone. Med. Oncol. 39 (3), 32. https:\/\/doi.org\/10.3390\/cancers14225648 (2022).","journal-title":"Med. Oncol."},{"key":"51716_CR47","doi-asserted-by":"publisher","unstructured":"Challenor, S. & Tucker, D. SARS-CoV-2-induced remission of Hodgkin lymphoma. (2021). https:\/\/doi.org\/10.1111\/bjh.17116","DOI":"10.1111\/bjh.17116"},{"key":"51716_CR48","doi-asserted-by":"publisher","unstructured":"de Sousa, L. G. et al. Spontaneous tumor regression following COVID-19 vaccination. J. Immunother. Cancer. 10 (3). https:\/\/doi.org\/10.1136\/jitc-2021-004371 (2022).","DOI":"10.1136\/jitc-2021-004371"},{"issue":"5","key":"51716_CR49","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molcel.2019.07.025","volume":"75","author":"T Uroda","year":"2019","unstructured":"Uroda, T. et al. Conserved pseudoknots in lncRNA MEG3 are essential for stimulation of the p53 pathway. Mol. Cell. 75 (5), 982\u2013995. https:\/\/doi.org\/10.1016\/j.molcel.2019.07.025 (2019). e9.","journal-title":"Mol. Cell"},{"issue":"10","key":"51716_CR50","doi-asserted-by":"publisher","first-page":"e0139790","DOI":"10.1371\/journal.pone.0139790","volume":"10","author":"J Zhu","year":"2015","unstructured":"Zhu, J. et al. Long noncoding RNA MEG3 interacts with p53 protein and regulates partial p53 target genes in hepatoma cells. PloS one. 10 (10), e0139790. https:\/\/doi.org\/10.1371\/journal.pone.0139790 (2015).","journal-title":"PloS one"},{"issue":"2","key":"51716_CR51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/ijo.2015.3285","volume":"48","author":"J Li","year":"2015","unstructured":"Li, J. et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas. Int. J. Oncol. 48 (2), 723\u2013733. https:\/\/doi.org\/10.3892\/ijo.2015.3285 (2015).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"51716_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbrc.2018.08.142","volume":"504","author":"J Xu","year":"2018","unstructured":"Xu, J. et al. Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation. Biochem. Biophys. Res. Commun. 504 (1), 123\u2013128. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.142 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"51716_CR53","doi-asserted-by":"publisher","first-page":"e2262","DOI":"10.1038\/cddis.2016.168","volume":"7","author":"R Singh","year":"2016","unstructured":"Singh, R. et al. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis. 7 (6), e2262\u2013e. https:\/\/doi.org\/10.1038\/cddis.2016.168 (2016).","journal-title":"Cell Death Dis."},{"issue":"8","key":"51716_CR54","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/cells9081859","volume":"9","author":"Y-K Su","year":"2020","unstructured":"Su, Y-K. et al. Targeting BC200\/miR218-5p signaling axis for overcoming temozolomide resistance and suppressing glioma stemness. Cells 9 (8), 1859. https:\/\/doi.org\/10.3390\/cells9081859 (2020).","journal-title":"Cells"},{"key":"51716_CR55","doi-asserted-by":"publisher","first-page":"155657","DOI":"10.1016\/j.cyto.2021.155657","volume":"148","author":"Z-L Tang","year":"2021","unstructured":"Tang, Z-L. et al. LncRNA MEG3 suppresses PI3K\/AKT\/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-\u03b1-treated keratinocytes and psoriatic mice. Cytokine 148, 155657. https:\/\/doi.org\/10.1016\/j.cyto.2021.155657 (2021).","journal-title":"Cytokine"},{"key":"51716_CR56","doi-asserted-by":"publisher","unstructured":"Sun, Y., Cao, F-L., Qu, L-L., Wang, Z-M. & Liu, X-Y. MEG3 promotes liver cancer by activating PI3K\/AKT pathway through regulating AP1G1. Eur. Rev. Med. Pharmacol. Sci. 23 (4). https:\/\/doi.org\/10.26355\/eurrev_201902_17103 (2019).","DOI":"10.26355\/eurrev_201902_17103"},{"issue":"5","key":"51716_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3892\/ol.2021.12606","volume":"21","author":"D Wu","year":"2021","unstructured":"Wu, D., Ma, Z., Ma, D. & Li, Q. Long non-coding RNA maternally expressed gene 3 affects cell proliferation, apoptosis and migration by targeting the microRNA-9-5p\/midkine axis and activating the phosphoinositide-dependent kinase\/AKT pathway in hepatocellular carcinoma. Oncol. Lett. 21 (5), 345. https:\/\/doi.org\/10.3892\/ol.2021.12606 (2021).","journal-title":"Oncol. Lett."},{"issue":"1","key":"51716_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y. et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal. Transduct. Target. therapy. 6 (1), 425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5 (2021).","journal-title":"Signal. Transduct. Target. therapy"},{"issue":"6","key":"51716_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.18632\/oncotarget.293","volume":"2","author":"JR Hart","year":"2011","unstructured":"Hart, J. R. & Vogt, P. K. Phosphorylation of AKT: a mutational analysis. Oncotarget 2 (6), 467. https:\/\/doi.org\/10.18632\/oncotarget.293 (2011).","journal-title":"Oncotarget"},{"issue":"1","key":"51716_CR60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41698-024-00554-5","volume":"8","author":"O Timofeev","year":"2024","unstructured":"Timofeev, O., Giron, P., Lawo, S., Pichler, M. & Noeparast, M. ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework. npj Precision Oncol. 8 (1), 70. https:\/\/doi.org\/10.1038\/s41698-024-00554-5 (2024).","journal-title":"npj Precision Oncol."},{"issue":"2","key":"51716_CR61","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3892\/mmr.2018.9712","volume":"19","author":"J Zou","year":"2019","unstructured":"Zou, J. et al. Mechanisms shaping the role of ERK1\/2 in cellular senescence. Mol. Med. Rep. 19 (2), 759\u2013770. https:\/\/doi.org\/10.3892\/mmr.2018.9712 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"21","key":"51716_CR62","doi-asserted-by":"publisher","first-page":"18811","DOI":"10.1074\/jbc.M301010200","volume":"278","author":"R Ley","year":"2003","unstructured":"Ley, R., Balmanno, K., Hadfield, K., Weston, C. & Cook, S. J. Activation of the ERK1\/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278 (21), 18811\u201318816. https:\/\/doi.org\/10.1074\/jbc.M301010200 (2003).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"51716_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12931-023-02373-x","volume":"24","author":"L Ting","year":"2023","unstructured":"Ting, L., Feng, Y., Zhou, Y., Tong, Z. & Dong, Z. IL-27 induces autophagy through regulation of the DNMT1\/lncRNA MEG3\/ERK\/p38 axis to reduce pulmonary fibrosis. Respir. Res. 24 (1), 67. https:\/\/doi.org\/10.1186\/s12931-023-02373-x (2023).","journal-title":"Respir. Res."},{"key":"51716_CR64","doi-asserted-by":"publisher","unstructured":"Fang, X. et al. Possible involvement of a MEG3-miR-21-SPRY1-NF-\u03baB feedback loop in spermatogenic cells proliferation, autophagy, and apoptosis. Iscience 27 (10). https:\/\/doi.org\/10.1016\/j.isci.2024.110904 (2024).","DOI":"10.1016\/j.isci.2024.110904"},{"issue":"21","key":"51716_CR65","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3389\/fonc.2023.1264090","volume":"21","author":"T Pan","year":"2022","unstructured":"Pan, T. et al. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway. Cell. Cycle. 21 (21), 2323\u20132337. https:\/\/doi.org\/10.3389\/fonc.2023.1264090 (2022).","journal-title":"Cell. Cycle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51716-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:03:00Z","timestamp":1783036980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51716-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51716"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51716-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20464"}}